Moderna | MRNA - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Arrowhead Research USD 16.87M 7.18M 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Celltrion KRW 779M 157.66M 2026-03
Dianthus Therapeutics USD 6.26M 2.61M 2026-03
Gilead Sciences USD 95M 0 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Kangmei Pharma CNY 2.44M 635.78K 2026-03
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Moderna USD 72M 2M 2026-03
Pharma Mar EUR 1.63M 3.17M 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Qiagen NV USD 10.56M 9.44M 2026-03
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Sartorius EUR 14.8M 5.3M 2026-06
Tilray USD 12.83M 20.19M 2024-05
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
United Therapeutics USD 31.5M 10.3M 2026-06
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03
Zealand Pharma A/S 74M 28.41M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M 2026-03